Janon, Mia .

HRN: 21-51-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2022
CEFUROXIME 500MG (TAB)
06/28/2022
07/05/2022
PO
500mg
Q12
UTI
Waiting Final Action 
10/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/30/2022
11/05/2022
IV
500mg
Q8
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: